In 95% of patients with hair loss, it is inherited. Specifically, it is the genetic code that the hair follicles receive during their training in the uterus.
Some hair follicles are sensitive to the hormone DHT, or dihydrotestosterone.
Latest scientific findings
Took place in 1995 important scientific discoveries related to baldness. Various botanical substances shown to be potent inhibitors of metabolism responsible for loosing hair loss in men and women.
Hereditary baldness shares a large number of patterns with benign prostatic hyperplasia (BPH).
Certain botanical compounds have demonstrated the ability to inhibit the mechanisms associated with BPH.
Based on the parallel etiologies of these two disorders in the body is that investigated the benefits of these botanicals in the treatment of hereditary baldness.
It was found that the enzyme 5-alpha reductase (5AR) converts the hormone testosterone into dihydrotestosterone, or DHT. The DHT precipitated the most common form of baldness, androgenetic baldness or hereditary.
1 . The DHT is housed in specific points of the follicle known as androgen receptacles, and that's when you start your action miniaturizante of the follicles.
The result is shorter hair, thin, weak and at one point virtually invisible (very light colored hair). Eventually the follicles die and stop producing hair.
2.The research also showed that the DHT is located at the base of the hair shaft or the root, where it produces a waxy substance around the roots and thereby restricts the flow of blood to the follicles and therefore, all the essential nutrients to keep hair healthy and strong.
Having a limited flow of blood to the follicles, cells of the same breed more slowly. This causes the follicles to become smaller, thereby shortening the growth phase and prolonged the decay phase of the hair.
While shortening the hair growth phase, hair quality degenerates, so that the hair becomes thinner, weaker and lighter colored. At the same time a fall occurs more frequently of such hair.
In April of 2002. The Journal of Alternative and Complementary Medicine is a prestigious publication in the medical field, authorized for publication the manuscript containing the remarkable results of clinical trials of blocking DHT naturally derived, produced by an independent study under the supervision of the FDA (Food and Drug Administration).
This study represents the first successful case of using natural formulations to treat androgenetic alopecia or hereditary baldness is a paradigm shift in terms of traditional clinical approach for the treatment of baldness, since it introduces the natural DHT blockers as a truly safe alternative and more effective pharmaceutical drugs formulated with Minoxidil and Finasteride.
